Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery
Status:
Completed
Trial end date:
2019-02-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy, toxicity and feasibility of FOLFOX/
bevacizumab and FOLFOXIRI/ bevacizumab neoadjuvant therapy in poor prognosis rectal cancer as
defined by MRI.